During collection and storage, platelets develop a variety of structural and in vitro functional abnormalities, including alterations in surface membrane constituents, granule release, signal transduction, membrane phospholipid composition, energy metabolism and cytoskeletal organization. The development of this platelet storage lesion is the result of platelet activation, opsonization, hypermetabolism and senescence. It is also known that upon transfusion some of these in vitro abnormalities reverse; however, the definition of which abnormalities are readily reversible and which are irreversible is not well understood. Based on preliminary data, we hypothesize that (a) abnormalities previously thought to be irreversible may not be so, for example, P-selectin expression on the platelet surface; (b) a significant portion of both the activation-derived and the opsonization- derived platelet lesion is secondary to complement activation during collection and storage; and (c) that a portion of the metabolic abnormalities observed are also directly linked to platelet activation via mitochondrial dysfunction induced by normal activation events. We have developed an in vitro whole blood model of transfusion that allows one to separately analyze subsets of """"""""transfused"""""""" platelets simultaneously with native platelets. In addition, we have previously investigated in detail the participation of specific complement components in the development of the somewhat analogous platelet lesion which is associated with extracorporeal circulation and now have preliminary data to suggest similar complement participation in the storage lesion. We now propose to: (a) define which aspects of the platelet storage lesion are reversible upon reintroduction of the stored platelets into the normal whole blood milieu using the transfusion model; and (b) define the role of specific complement components in the generation of the activation, opsonization and metabolic storage lesion under different conditions of collection and storage. We will use specific blocking molecules, multiparameter flow cytometric and image analysis technology, cytoskeletal and signal transduction analysis and newly applied metabolic assays. The long term goal of the project, which combines the synergistic expertise of several established investigators, is to improve the clinical results of platelet transfusion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061223-02
Application #
6056553
Study Section
Special Emphasis Panel (ZHL1-CSR-N (S1))
Project Start
1998-09-30
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kosten, Thomas R; Tucker, Karen; Gottschalk, P Christopher et al. (2004) Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence. Biol Psychiatry 55:91-7
Paglino, Justin C; Pomper, Gregory J; Fisch, Gene S et al. (2004) Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 44:16-24
Patel, Parag B; Pfau, Steven E; Cleman, Michael W et al. (2004) Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. Am J Cardiol 93:410-3
Angelopoulou, Maria K; Rinder, Henry; Wang, Chao et al. (2004) A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment. Transfusion 44:555-66
Rinder, Henry M; Snyder, Edward L; Tracey, Jayne B et al. (2003) Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 43:1230-7
Kosten, Thomas R; Gottschalk, P Christopher; Tucker, Karen et al. (2003) Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug Alcohol Depend 71:187-94
Rinder, Henry M; Smith, Brian R (2003) In vitro evaluation of stored platelets: is there hope for predicting posttransfusion platelet survival and function? Transfusion 43:2-6
Perrotta, Peter L; Perrotta, Cheryl L; Snyder, Edward L (2003) Apoptotic activity in stored human platelets. Transfusion 43:526-35
Wang, Chao; Smith, Brian R; Ault, Kenneth A et al. (2002) Reticulated platelets predict platelet count recovery following chemotherapy. Transfusion 42:368-74
Perez, L E; Rinder, H M; Wang, C et al. (2001) Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood 97:1635-43

Showing the most recent 10 out of 11 publications